Genta Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Genta Inc. - overview
Established
1988
Location
Berkeley Heights, NJ, US
Primary Industry
Pharmaceuticals
About
Founded in 1988 and based in New Jersey, US, Genta Inc. operates as a biopharmaceutical company that develops drugs for the treatment of cancer and related diseases. It offers Tesetaxel, a novel taxane compound that is taken by mouth, and Ganite, an intravenous formulation of gallium nitrate for treatment of cancer-related hypercalcemia.
Current Investors
Narragansett Capital Partners, S.G. Cowen Ventures, Federated Hermes
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Verticals
Manufacturing
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Genta Inc. - financials
| Fiscal Year Ended | Dec 31, 2002 | Dec 31, 2003 | Dec 31, 2004 | Dec 31, 2005 | Dec 31, 2006 | Dec 31, 2007 | Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 3,559,000 | 6,659,000 | 14,615,000 | 26,585,000 | 708,000 | 580,000 | 363,000 | - | - | - |
| % Revenue Growth (YoY) | - | 87.1% | 119.5% | 81.9% | (97.3%) | (18.1%) | (37.4%) | - | - | - |
| EBITDA (USD) | (74,057,000) | (48,386,000) | (45,713,000) | (26,738,000) | (57,912,000) | (25,297,000) | (494,964,000) | - | - | - |
| Operating Income (USD) | (75,703,000) | (50,769,000) | (33,589,000) | (2,584,000) | (58,854,000) | (25,467,000) | (506,347,000) | - | - | - |
| Operating Margin | (2127.1%) | (762.4%) | (229.8%) | (9.7%) | (8312.7%) | (4390.9%) | (139489.5%) | - | - | - |
| % EBITDA Margin | (2080.8%) | (726.6%) | (312.8%) | (100.6%) | (8179.7%) | (4361.6%) | (136353.7%) | - | - | - |
| NET Income (USD) | (74,528,000) | (50,109,000) | (32,685,000) | (2,203,000) | (56,781,000) | (23,320,000) | (505,838,000) | - | - | - |
| % Net Margin | (2094.1%) | (752.5%) | (223.6%) | (8.3%) | (8019.9%) | (4020.7%) | (139349.3%) | - | - | - |
Genta Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.